BioCentury - Alzheimer's play Alzheon files for IPO
BioCentury,
Alzheon Inc. (Framingham, Mass.) filed to raise up to $80.5 million in an IPO on NASDAQ underwritten by Citigroup, Piper Jaffray…
Alzheon Inc. (Framingham, Mass.) filed to raise up to $80.5 million in an IPO on NASDAQ underwritten by Citigroup, Piper Jaffray…
14 Dec 2017 They are difficult to isolate, hard to quantify, and virtually uncharacterized structurally.
A Alzheon Presents New Data for Lead Candidate ALZ801 on Novel MOA and LongTerm Clinical Efficacy at the Alzheimer's…
FRAMINGHAM, Mass.--(Business Wire)-- Alzheon, Inc., a clinical stage biopharmaceutical company focused on developing new…